Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/17/2025 | $55.00 | Outperform | Wolfe Research |
| 6/11/2025 | $65.00 | Strong Buy | Raymond James |
| 3/13/2025 | $70.00 | Buy | Citigroup |
| 3/12/2025 | $72.00 | Outperform | BMO Capital Markets |
| 3/7/2025 | $70.00 | Sector Outperform | Scotiabank |
| 12/20/2024 | $72.00 | Buy | H.C. Wainwright |
| 11/26/2024 | $67.00 | Outperform | RBC Capital Mkts |
| 9/24/2024 | $59.00 | Buy | Goldman |
Wolfe Research initiated coverage of Avidity Biosciences with a rating of Outperform and set a new price target of $55.00
Raymond James initiated coverage of Avidity Biosciences with a rating of Strong Buy and set a new price target of $65.00
Citigroup initiated coverage of Avidity Biosciences with a rating of Buy and set a new price target of $70.00